Linqmed
Developer of radiopharmaceuticals designed to offer treatment for cancer. The company engages in the research and development of therapeutic and diagnostic drugs for cancer using 64Cu, which is a radi...
Valuation
$44.8M
Market implied
Share Price
N/A
Total Raised
$32.6M
Last Round
N/A